SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,517,000 | -33.7% | 195,489 | -12.5% | 1.29% | -4.7% |
| Q4 2019 | $5,301,000 | -16.9% | 223,490 | -3.7% | 1.35% | -22.6% |
| Q3 2019 | $6,376,000 | +1.3% | 232,030 | +21.9% | 1.75% | +0.3% |
| Q2 2019 | $6,297,000 | +4.6% | 190,290 | +10.7% | 1.74% | +5.2% |
| Q1 2019 | $6,022,000 | -33.9% | 171,870 | -37.4% | 1.65% | -41.5% |
| Q4 2018 | $9,117,000 | -19.6% | 274,457 | +21.9% | 2.83% | -2.3% |
| Q3 2018 | $11,340,000 | +76.9% | 225,232 | +110.3% | 2.90% | +68.0% |
| Q2 2018 | $6,409,000 | +0.3% | 107,080 | -23.3% | 1.72% | +0.2% |
| Q1 2018 | $6,391,000 | +18.9% | 139,535 | +3.5% | 1.72% | +18.0% |
| Q4 2017 | $5,373,000 | +20.4% | 134,820 | +20.8% | 1.46% | +14.4% |
| Q3 2017 | $4,464,000 | -11.5% | 111,600 | -4.6% | 1.28% | -15.3% |
| Q2 2017 | $5,043,000 | +32.4% | 117,000 | -3.8% | 1.50% | +27.5% |
| Q1 2017 | $3,808,000 | +24.2% | 121,660 | +0.2% | 1.18% | +15.3% |
| Q4 2016 | $3,066,000 | +94.3% | 121,440 | +90.4% | 1.02% | +75.5% |
| Q3 2016 | $1,578,000 | +117.4% | 63,795 | +79.0% | 0.58% | +107.5% |
| Q2 2016 | $726,000 | – | 35,630 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |